ClinicalTrials.Veeva

Menu

Berlin Atrial Fibrillation Registry

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Completed

Conditions

Atrial Fibrillation
Acute Ischemic Stroke

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02306824
EA2/052/14

Details and patient eligibility

About

Investigator-initiated prospective multicentre hospital-based registry to uncover the proportion of self-reported anticoagulation in stroke patients with atrial fibrillation and assessing the proportion of stroke, intracranial bleeding and all-cause death in the short (at 3 months), mid-term (at 12 months) as well as long term (at 24 months) after ischemic stroke or transient ischemic attack in an unselected urban population in Germany. In addition, annual follow-up is planned yearly up to 5 years after enrollment.

Enrollment

1,080 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute ischemic stroke or transient ischemic attack (with clinical deficit on admission or corresponding brain MRI lesion)
  • Age ≥ 18 years
  • Known atrial fibrillation or ECG recording documenting atrial fibrillation during the in-hospital stay for acute ischemic stroke or transient ischemic attack
  • Written or oral informed consent
  • Willingness to take part in the planned follow up examinations

Exclusion criteria

  • Life expectancy < 1 year (before stroke)
  • Assumed post-stroke life expectancy < 1 month according to stroke severity
  • Chronic anticoagulation for reasons other than atrial fibrillation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems